June 28, 2022 C-Path Welcomes Parexel C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 24, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Progressing BYOD Adoption” has been published in Applied Clinical Tria
June 22, 2022 C-Path Receives DIA 2022 Americas Inspire Award for Outstanding Contribution to Health TUCSON, Ariz., June 22, 2022 — Critical Path Institute (C-Path) is pleased to announce it has received the DIA 2022 Ameri
June 15, 2022 View Now | Using Ontologies to Standardize Rare Disease Data Collection presented by Monarch Initiative This webinar will provide an overview of biomedical ontologies and demonstrate how they can be used for standardizing and integrat
June 9, 2022 C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 — Criti
June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
June 8, 2022 Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): measurement properties and estimated clinically meaningful thresholds from a phase 3 study
June 7, 2022 C-Path and MitoAction Announce Data Sharing Agreement to Support Treatment Development in Mitochondrial Disease TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorpora